GENE ONLINE|News &
Opinion
Blog

Licensing
Licensing FDA ApprovalAnaphylaxis
The First-Ever Nasal Spray for Anaphylactic Shock Gets FDA Approval
2024-08-12
Deals Acquisitions
Merck Strikes $1.3 Billion Deal to Acquire Curon’s B-Cell Therapy Drug
2024-08-12
Licensing RocheDiabetesEU Approval
Roche Secures CE Mark for AI-Powered Glucose Monitoring Solution, Enhancing Diabetes Care with Predictive Insights
2024-07-11
Partnerships Novo NordiskTargeted Protein Degradation
Neomorph Links Together With Novo Nordisk in a $1.46 Billion Molecular Glue Partnership Deal
2024-02-27
Licensing Astellas PharmaGene Therapy
Astellas Secures Licensing Agreement with 4D Molecular Therapeutics for Gene Therapy Vector Technology
2023-07-12
Partnerships Johnson & JohnsonCAR T-cell Therapy
J&J Puts Up $245 Million for Two Promising Autologous CAR-T Candidates
2023-05-05
Licensing Antibiotic Treatment
GSK Bets $593 Million To License Scynexis’ Oral Antifungal
2023-03-31
Licensing
Vertex and CRISPR Collaborate Again with $330 Million Diabetes Gene Editing Deal
2023-03-28
Licensing Lipid Nanoparticle
Moderna Injects $76 Million To Kickstart Lipid Nanoparticle Delivery Partnership With Generation Bio
2023-03-24
Licensing JAK Inhibitor
Biohaven Licenses TYK2/JAK1 Dual Inhibitor From China’s Highlight In $970 Million Pact
2023-03-23
Licensing Antibody Therapy
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
Licensing Epstein-Barr Virus
Merck Strikes $50 Million Deal with ModeX For Rights to EBV Vaccine
2023-03-08
Licensing Allogeneic Cell Therapy
Lineage Books Eterna For Allogeneic Cell Therapies In License Option Deal
2023-02-23
Licensing Anxiety
Karuna Licenses Goldfinch’s Mood Disorder Candidates For Potential $535 Million
2023-02-03
Asia-Pacific Antibody-Drug Conjugate
Following Amgen, Hummingbird Jumps Onto Synaffix’s ADC Platform In $150 Million Licensing Deal
2023-01-06
1 2 3 … 7
LATEST
Bayer’s NUBEQA: Breakthrough in Prostate Cancer with 46% Risk Reduction and Future FDA Expansion Plans
2024-09-19
Highlights from ESMO 2024: Key Oncology Advances from Major Pharmaceutical Companies
2024-09-19
Five Biotech Stocks Soar: Eyes on Halozyme, United Therapeutics, Harmony, Ligand, and ADMA
2024-09-19
Biotech Industry Trends in 2024: A Look at the Billions in Oncology Deals
2024-09-18
Thailand’s Biotech Boom: Innovations in Precision Medicine, Cell Therapy, and Wellness Drive APAC Leadership
2024-09-18
International Green Party Showcases AI Solutions for a Healthy and Sustainable Future
2024-09-16
Bio Asia Pacific 2024 Close ASEAN Collaborations: Catalyzing Innovation and Global Partnerships
2024-09-12
READ MORE
EVENT
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-10
BioJapan / Regenerative Medicine Japan / healthTECH JAPAN 2024
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top